Therapeutic efficacy of cardiosphere-derived cells in a transgenic mouse model of non-ischaemic dilated cardiomyopathy

Mohammad A. Aminzadeh, Eleni Tseliou, Baiming Sun, Ke Cheng, Konstantinos Malliaras, Raj R. Makkar, Eduardo Marbán

Research output: Contribution to journalArticle

Abstract

Aim: Cardiosphere-derived cells (CDCs) produce regenerative effects in the post-infarct setting. However, it is unclear whether CDCs are beneficial in non-ischaemic dilated cardiomyopathy (DCM). We tested the effects of CDC transplantation in mice with cardiac-specific Gαq overexpression, which predictably develop progressive cardiac dilation and failure, with accelerated mortality. Methods and results: Wild-type mouse CDCs (105 cells) or vehicle only were injected intramyocardially in 6-, 8-, and 11-week-old Gαq mice. Cardiac function deteriorated in vehicle-treated mice over 3 months of follow-up, accompanied by oxidative stress, inflammation and adverse ventricular remodelling. In contrast, CDCs preserved cardiac function and volumes, improved survival, and promoted cardiomyogenesis while blunting Gαq-induced oxidative stress and inflammation in the heart. The mechanism of benefit is indirect, as long-term engraftment of transplanted cells is vanishingly low. Conclusions: Cardiosphere-derived cells reverse fundamental abnormalities in cell signalling, prevent adverse remodelling, and improve survival in a mouse model of DCM. The ability to impact favourably on disease progression in non-ischaemic heart failure heralds new potential therapeutic applications of CDCs.

Original languageEnglish (US)
Pages (from-to)751-762
Number of pages12
JournalEuropean Heart Journal
Volume36
Issue number12
DOIs
StatePublished - Mar 21 2015
Externally publishedYes

Fingerprint

Dilated Cardiomyopathy
Transgenic Mice
Therapeutics
Oxidative Stress
Heart Failure
Inflammation
Cardiac Volume
Ventricular Remodeling
Cell Transplantation
Disease Progression
Dilatation
Mortality

Keywords

  • Cardiomyopathy
  • Cell transplantation
  • Heart failure

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Aminzadeh, M. A., Tseliou, E., Sun, B., Cheng, K., Malliaras, K., Makkar, R. R., & Marbán, E. (2015). Therapeutic efficacy of cardiosphere-derived cells in a transgenic mouse model of non-ischaemic dilated cardiomyopathy. European Heart Journal, 36(12), 751-762. https://doi.org/10.1093/eurheartj/ehu196

Therapeutic efficacy of cardiosphere-derived cells in a transgenic mouse model of non-ischaemic dilated cardiomyopathy. / Aminzadeh, Mohammad A.; Tseliou, Eleni; Sun, Baiming; Cheng, Ke; Malliaras, Konstantinos; Makkar, Raj R.; Marbán, Eduardo.

In: European Heart Journal, Vol. 36, No. 12, 21.03.2015, p. 751-762.

Research output: Contribution to journalArticle

Aminzadeh, MA, Tseliou, E, Sun, B, Cheng, K, Malliaras, K, Makkar, RR & Marbán, E 2015, 'Therapeutic efficacy of cardiosphere-derived cells in a transgenic mouse model of non-ischaemic dilated cardiomyopathy', European Heart Journal, vol. 36, no. 12, pp. 751-762. https://doi.org/10.1093/eurheartj/ehu196
Aminzadeh, Mohammad A. ; Tseliou, Eleni ; Sun, Baiming ; Cheng, Ke ; Malliaras, Konstantinos ; Makkar, Raj R. ; Marbán, Eduardo. / Therapeutic efficacy of cardiosphere-derived cells in a transgenic mouse model of non-ischaemic dilated cardiomyopathy. In: European Heart Journal. 2015 ; Vol. 36, No. 12. pp. 751-762.
@article{55da723d52c74685a2410d8180d36165,
title = "Therapeutic efficacy of cardiosphere-derived cells in a transgenic mouse model of non-ischaemic dilated cardiomyopathy",
abstract = "Aim: Cardiosphere-derived cells (CDCs) produce regenerative effects in the post-infarct setting. However, it is unclear whether CDCs are beneficial in non-ischaemic dilated cardiomyopathy (DCM). We tested the effects of CDC transplantation in mice with cardiac-specific Gαq overexpression, which predictably develop progressive cardiac dilation and failure, with accelerated mortality. Methods and results: Wild-type mouse CDCs (105 cells) or vehicle only were injected intramyocardially in 6-, 8-, and 11-week-old Gαq mice. Cardiac function deteriorated in vehicle-treated mice over 3 months of follow-up, accompanied by oxidative stress, inflammation and adverse ventricular remodelling. In contrast, CDCs preserved cardiac function and volumes, improved survival, and promoted cardiomyogenesis while blunting Gαq-induced oxidative stress and inflammation in the heart. The mechanism of benefit is indirect, as long-term engraftment of transplanted cells is vanishingly low. Conclusions: Cardiosphere-derived cells reverse fundamental abnormalities in cell signalling, prevent adverse remodelling, and improve survival in a mouse model of DCM. The ability to impact favourably on disease progression in non-ischaemic heart failure heralds new potential therapeutic applications of CDCs.",
keywords = "Cardiomyopathy, Cell transplantation, Heart failure",
author = "Aminzadeh, {Mohammad A.} and Eleni Tseliou and Baiming Sun and Ke Cheng and Konstantinos Malliaras and Makkar, {Raj R.} and Eduardo Marb{\'a}n",
year = "2015",
month = "3",
day = "21",
doi = "10.1093/eurheartj/ehu196",
language = "English (US)",
volume = "36",
pages = "751--762",
journal = "European Heart Journal",
issn = "0195-668X",
publisher = "Oxford University Press",
number = "12",

}

TY - JOUR

T1 - Therapeutic efficacy of cardiosphere-derived cells in a transgenic mouse model of non-ischaemic dilated cardiomyopathy

AU - Aminzadeh, Mohammad A.

AU - Tseliou, Eleni

AU - Sun, Baiming

AU - Cheng, Ke

AU - Malliaras, Konstantinos

AU - Makkar, Raj R.

AU - Marbán, Eduardo

PY - 2015/3/21

Y1 - 2015/3/21

N2 - Aim: Cardiosphere-derived cells (CDCs) produce regenerative effects in the post-infarct setting. However, it is unclear whether CDCs are beneficial in non-ischaemic dilated cardiomyopathy (DCM). We tested the effects of CDC transplantation in mice with cardiac-specific Gαq overexpression, which predictably develop progressive cardiac dilation and failure, with accelerated mortality. Methods and results: Wild-type mouse CDCs (105 cells) or vehicle only were injected intramyocardially in 6-, 8-, and 11-week-old Gαq mice. Cardiac function deteriorated in vehicle-treated mice over 3 months of follow-up, accompanied by oxidative stress, inflammation and adverse ventricular remodelling. In contrast, CDCs preserved cardiac function and volumes, improved survival, and promoted cardiomyogenesis while blunting Gαq-induced oxidative stress and inflammation in the heart. The mechanism of benefit is indirect, as long-term engraftment of transplanted cells is vanishingly low. Conclusions: Cardiosphere-derived cells reverse fundamental abnormalities in cell signalling, prevent adverse remodelling, and improve survival in a mouse model of DCM. The ability to impact favourably on disease progression in non-ischaemic heart failure heralds new potential therapeutic applications of CDCs.

AB - Aim: Cardiosphere-derived cells (CDCs) produce regenerative effects in the post-infarct setting. However, it is unclear whether CDCs are beneficial in non-ischaemic dilated cardiomyopathy (DCM). We tested the effects of CDC transplantation in mice with cardiac-specific Gαq overexpression, which predictably develop progressive cardiac dilation and failure, with accelerated mortality. Methods and results: Wild-type mouse CDCs (105 cells) or vehicle only were injected intramyocardially in 6-, 8-, and 11-week-old Gαq mice. Cardiac function deteriorated in vehicle-treated mice over 3 months of follow-up, accompanied by oxidative stress, inflammation and adverse ventricular remodelling. In contrast, CDCs preserved cardiac function and volumes, improved survival, and promoted cardiomyogenesis while blunting Gαq-induced oxidative stress and inflammation in the heart. The mechanism of benefit is indirect, as long-term engraftment of transplanted cells is vanishingly low. Conclusions: Cardiosphere-derived cells reverse fundamental abnormalities in cell signalling, prevent adverse remodelling, and improve survival in a mouse model of DCM. The ability to impact favourably on disease progression in non-ischaemic heart failure heralds new potential therapeutic applications of CDCs.

KW - Cardiomyopathy

KW - Cell transplantation

KW - Heart failure

UR - http://www.scopus.com/inward/record.url?scp=84940047064&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84940047064&partnerID=8YFLogxK

U2 - 10.1093/eurheartj/ehu196

DO - 10.1093/eurheartj/ehu196

M3 - Article

C2 - 24866210

AN - SCOPUS:84940047064

VL - 36

SP - 751

EP - 762

JO - European Heart Journal

JF - European Heart Journal

SN - 0195-668X

IS - 12

ER -